Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0RC9T
|
||||
Former ID |
DNC003992
|
||||
Drug Name |
2-Phenyl-3-piperidin-3-yl-1H-indole
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C19H20N2
|
||||
Canonical SMILES |
C1CC(CNC1)C2=C(NC3=CC=CC=C32)C4=CC=CC=C4
|
||||
InChI |
1S/C19H20N2/c1-2-7-14(8-3-1)19-18(15-9-6-12-20-13-15)16-10-4-5-11-17(16)21-19/h1-5,7-8,10-11,15,20-21H,6,9,12-13H2
|
||||
InChIKey |
FYHCOUIJWCQUMZ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [1] | |
PathWhiz Pathway | Muscle/Heart Contraction | ||||
Reactome | Voltage gated Potassium channels | ||||
WikiPathways | SIDS Susceptibility Pathways | ||||
Hematopoietic Stem Cell Differentiation | |||||
Potassium Channels | |||||
References | |||||
REF 1 | J Med Chem. 2001 May 10;44(10):1603-14.3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.